Vascular Graft Market to Reach USD 4.4 Bn by 2031, Driven by Cardiovascular Burden and Endovascular Innovation | Braun Melsungen AG, Bard Peripheral Vascular Inc, Cryolife, Getinge Group, LeMaitre Vascular Inc

The Vascular Graft market was valued at USD 2,483.29 million in 2022 and is projected to grow significantly, reaching approximately USD 4,404.04 million by 2031. This reflects a compound annual growth rate (CAGR) of 7.6% during the forecast period from 2024 to 2031.

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/vascular-graft-market?sg

Key Market Drivers:
✅ Rising Prevalence of Cardiovascular and Peripheral Artery Diseases
Increasing rates of diabetes, hypertension, and smoking are contributing to a global surge in vascular conditions. As these diseases often require surgical interventions, demand for vascular grafts continues to rise.

✅ Growing Geriatric Population
Aging is a major risk factor for atherosclerosis and aneurysms, leading to a higher requirement for bypass grafts and vascular reconstruction. This demographic shift is a critical driver of market expansion.

✅ Technological Advancements in Graft Materials
Innovations in biomaterials and graft design, such as heparin-bonded and drug-eluting grafts, are improving patient outcomes, reducing complications, and boosting surgeon confidence in these products.

✅ Expansion of Dialysis Procedures
With chronic kidney disease on the rise, vascular access grafts are increasingly used in hemodialysis. The growing global dialysis population is a significant contributor to overall graft demand.

✅ Increase in Minimally Invasive Surgeries
The preference for less invasive procedures is encouraging the adoption of endovascular grafts. These techniques offer shorter recovery times, fewer complications, and have become a preferred treatment for abdominal and thoracic aortic aneurysms.

✅ Government Initiatives and Healthcare Funding
Public health programs and supportive reimbursement policies in developed and emerging nations are facilitating greater access to vascular procedures, thereby driving market growth.

Market Segments:
• By Product (Hemodialysis Access Graft, Endovascular Aneurysm Repair Stent Graft, and Peripheral Vascular Graft)
• By Raw Material (Polyester, Polytetrafluoroethylene (PTFE), Polyurethane, and Biosynthetic)
• By End-User (Hospitals and Ambulatory Surgical Centers (ASCs))
• By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/vascular-graft-market?sg

Vascular Graft Market - Geographical Share
The vascular graft market exhibits a strong global presence, with regional dynamics shaped by healthcare infrastructure, prevalence of vascular diseases, and access to advanced surgical procedures.

• North America holds the dominant market share, driven by a high incidence of cardiovascular and peripheral artery diseases, advanced healthcare systems, and the widespread availability of minimally invasive procedures. The U.S., in particular, benefits from strong adoption of endovascular grafts and robust R&D investment.

• Europe follows closely, led by countries such as Germany, France, and the UK. The region benefits from well-established public healthcare, increasing aging population, and steady demand for vascular surgeries and hemodialysis access grafts.

• Asia-Pacific is emerging as the fastest-growing region due to rising healthcare expenditure, expanding patient pool, and increasing awareness of vascular disorders. Countries like China, India, and Japan are experiencing a surge in demand, driven by lifestyle diseases and improving surgical capabilities.

DataM Intelligence Opinion:
The vascular graft market is poised for robust growth, primarily fueled by the rising global burden of cardiovascular and peripheral artery diseases conditions closely tied to diabetes, hypertension, and aging. With a rapidly expanding geriatric population and increasing cases of chronic kidney disease necessitating hemodialysis, the demand for vascular grafts is becoming more pronounced. Technological advancements particularly in heparin-bonded, drug-eluting, and biosynthetic grafts are improving clinical outcomes and enhancing the adoption of grafts in both open and minimally invasive procedures. Moreover, the rise in endovascular interventions reflects a broader shift toward faster, safer, and less invasive surgical solutions.

Regionally, North America leads due to its high disease prevalence, mature healthcare infrastructure, and strong emphasis on innovation and R&D. Europe remains a key contributor, supported by favorable healthcare policies and an aging population with consistent demand for vascular surgeries. However, Asia-Pacific is emerging as the fastest-growing market, driven by increasing healthcare access, rising awareness of vascular conditions, and a growing middle class seeking advanced treatment options. DataM Intelligence expects the market to continue expanding as healthcare systems invest in vascular care capacity and manufacturers focus on cost-effective, next-generation graft technologies to meet rising global demand.

Market Key Players:
Key players are Abbott Laboratories, Braun Melsungen AG, Bard Peripheral Vascular Inc., Cardinal Health (Cordis Corporation), Cook Medical, Cryolife, Getinge Group, LeMaitre Vascular Inc, Medtronic PLC, and W.L. Gore & Associates.

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?sg

2025 Highlights in the Vascular Graft Space:

✅ Bioengineered Vessels Get FDA Green Light
In December 2024, Humacyte a biotech pioneer from North Carolina secured FDA approval for its lab-grown, decellularized blood vessel intended for treating vascular trauma. Early data show a 92% patency rate at 30 days, outperforming traditional synthetic grafts. Its success substantially reduces infection and amputation rates compared to conventional options, marking a major leap in regenerative vascular solutions.

✅ Aortyx Secures €13.8M for Clinical Trials of Absorbable Vascular Patch
Barcelona-based medtech innovator Aortyx raised €13.8 million in a Serie A round (June 2025) to fund first-in-human trials of its bioabsorbable vascular patch. Developed via electrospinning, this catheter-deployed patch addresses aortic dissections a condition with high mortality by sealing tears and promoting tissue regeneration. The patch has already demonstrated encouraging results in preclinical models.

✅ Innovative Tissue Engineering via Deep Learning
In 2025, researchers introduced SeqSeg, a deep‐learning model that automates segmentation and modeling of vascular structures from CT/MRI data. It efficiently reconstructs 3D vasculature, outperforming traditional methods and streamlining model‐based planning in vascular care

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.